Pharmacelsus' Acquisition

Pharmacelsus was acquired by GBA Gesellschaft on March 20, 2017.

Pharmacelsus is a preclinical contract research organization. Pharmacelsus' service portfolio comprises the complete drug discovery and development testing program (in vitro, in vivo, ex vivo) as well…

Articles about Pharmacelsus' Acquisition: